This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dieu-Nosjean, M.-C. Articles by Cadranel, J. Search for Related Content PubMed PubMed Citation Articles by Dieu-Nosjean, M.-C. Articles by Cadranel, J. Pubmed/NCBI databases Medline Plus Health Information Lung Cancer Related Articles Related Editorial Social Bookmarking                            What's this?

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

Marie-Caroline Dieu-Nosjean, Martine Antoine, Claire Danel, Didier Heudes, Marie Wislez, Virginie Poulot, Nathalie Rabbe, Ludivine Laurans, Eric Tartour, Luc de Chaisemartin, Serge Lebecque, Wolf-Herman Fridman, Jacques Cadranel

From the Laboratoire Microenvironnement Immunitaire et Tumeurs, Institut National de la Santé et de la Recherche Médicale (INSERM) U872, Centre de Recherche des Cordeliers; Université Pierre et Marie Curie, UMR S872; Université Paris Descartes, UMR S872; Service d'Anatomie-Pathologie, Hôpital Tenon, AP-HP; Laboratoire de Biologie Cellulaire et d'Immunopathologie Pulmonaire, UPRES EA3493, Université Paris VI, Hôpital Tenon; Service d'Anatomie-Pathologie, Hôpital Européen Georges Pompidou, AP-HP; Service de Pneumologie et Réanimation Respiratoire, Hôpital Tenon, AP-HP; Laboratoire d'Immunologie, Hôpital Européen Georges Pompidou, AP-HP, Paris; INSERM U503, CERVI; and Centre Hospitalier Lyon Sud, Lyon, France

Corresponding author: Marie-Caroline Dieu-Nosjean, PhD, Laboratoire Microenvironnement Immunitaire et Tumeurs, INSERM UMR S872, Centre de Recherche des Cordeliers, 15 rue de l'école de Médecine, F-75270 Paris cedex 06, France; e-mail: mc.dieu-nosjean{at}crc.jussieu.fr

Purpose It has been established that the immune system plays an important role in tumor rejection. There is also compelling evidence that immune responses can develop independently of secondary lymphoid organs in tertiary lymphoid structures. We studied the presence and the correlation of tertiary lymphoid structures with clinical outcome in non–small-cell lung cancer (NSCLC), as the prognostic value of these structures in patients with cancer had not yet been established.

Patients and Methods This retrospective study was performed by immunohistochemistry on paraffin-embedded tissue specimens from 74 patients with early-stage NSCLC.

Results Tertiary lymphoid structures were detected in some tumors but not in nontumoral lungs. Thus we called these structures tumor-induced bronchus-associated lymphoid tissue (Ti-BALT). As in lymph nodes, Ti-BALTs were composed of mature dendritic cell (DC)/T-cell clusters adjacent to B-cell follicles and had features of an ongoing immune response. Because the quantitative counting of Ti-BALT was difficult to achieve, we used mature DCs that homed exclusively in Ti-BALT as a specific marker of these structures. Univariate analysis showed that the density of mature DCs was highly associated with a favorable clinical outcome (overall, disease-specific, and disease-free survival), suggesting that Ti-BALT may participate in antitumoral immunity. The density of tumor-infiltrating lymphocytes, in particular, CD4⁺ and T-bet⁺ Th1 T cells, was profoundly decreased in tumors weakly infiltrated by mature DCs.

Conclusion The density of mature DCs was found to be a better predictor of clinical outcome than the other parameters tested. The number of tumor-infiltrating mature DCs may identify patients with early-stage NSCLC who have a high risk of relapse.

Supported by Grant No. ARC n°C01-010 from Association pour la Recherche sur le Cancer through the Alliance pour la Recherche sur le Cancer network.

M.A. and C.D. contributed equally to this study.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Editorial

• Ectopic Lymph Nodes Within Human Solid Tumors
  Domenico Coppola and James J. Mulé
  JCO 2008 26: 4369-4370 [Full Text]

This article has been cited by other articles:

				C. Menetrier-Caux, M. Gobert, and C. Caux Differences in Tumor Regulatory T-Cell Localization and Activation Status Impact Patient Outcome Cancer Res., October 15, 2009; 69(20): 7895 - 7898. [Abstract] [Full Text] [PDF]

				A. Andersson, S.-C. Yang, M. Huang, L. Zhu, U. K. Kar, R. K. Batra, D. Elashoff, R. M. Strieter, S. M. Dubinett, and S. Sharma IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer J. Immunol., June 1, 2009; 182(11): 6951 - 6958. [Abstract] [Full Text] [PDF]

				D. Coppola and J. J. Mule Ectopic Lymph Nodes Within Human Solid Tumors J. Clin. Oncol., September 20, 2008; 26(27): 4369 - 4370. [Full Text] [PDF]